SDI Group has acquired PRP Optoelectronics for a net £9.3m (consideration: £11.3m cash on completion plus £0.8–0.9m deferred), funded from its HSBC UK revolving credit facility, taking the group into the avionics market and strengthening aerospace and defence supply-chain exposure. PRP reported unaudited FY2025 revenue of £5.99m, EBIT of £1.54m and net assets of £4.43m (including cash); SDI says the business has long-term agreements and blue‑chip customers (programmes cited include Eurofighter, F‑16 and F‑22). The deal will add to SDI’s Industrial & Scientific Sensors division and is expected to be earnings-enhancing in the first full year of ownership.
Market structure: SDI’s buy of PRP (~£12.1m consideration vs £6.0m 2025 revenue) is a classic bolt-on that immediately buys aerospace defence revenue visibility (long-term contracts, blue‑chip primes) and improves SDI’s product mix. Direct winners are SDI shareholders, avionics component suppliers with scale (greater cross‑sell optionality) and defence primes who get a nearer, qualified supply source; small independent LED makers and commodity LED suppliers may face pricing pressure. The deal’s EV/revenue ≈2x and EV/EBIT ≈7.8x imply modest valuation uplift potential; balance‑sheet funded via RCF raises leverage and therefore short‑term credit sensitivity that could modestly widen SDI’s credit spread and lengthen bond yields for similar small-cap issuers. Risk assessment: Tail risks include export/ITAR controls on avionics components, loss of one or two large prime contracts (concentrated revenue), and RCF covenant breach if rates or working capital swings materialise — low probability but high impact. Immediate (days) risk is a modest share repricing and covenant scrutiny; short term (weeks–months) is integration and margin accretion versus financing costs; long term (quarters–years) is technology obsolescence and dependency on defence budgets. Hidden dependencies: PRP’s “blue‑chip” book may be concentrated by programme (e.g., Eurofighter/F‑22 legacy lines) and susceptible to platform lifecycle; key catalysts are order confirmations, renewal of long‑term agreements, and RCF covenant filings. Trade implications: Direct: establish a tactical long in SDI (SDI.L) sized 2–3% of equity risk for a 6–12 month hold to capture first‑year accretion and M&A multiple re‑rating; hedge with 3‑month 10% OTM puts sized to 50% notional. Pair trade: long SDI.L vs short TTG.L (TT Electronics) 2:1 to play superior M&A execution/avionics exposure. Sector rotation: overweight Aerospace & Defence (e.g., ITA) by +1–2% for 6–12 months; take profits at +20% and cut at -10% within 3 months if covenant red flags appear. Contrarian angles: Consensus likely underestimates integration/contract concentration risk — the market may under‑price a potential one‑prime revenue shock. The accretion story could be overdone if PRP’s revenues are tied to legacy platforms rather than scalable new programmes; conversely, if PRP supplies classified platforms, export restrictions could create an entry barrier protecting margins. Historical parallels (small bolt‑ons to electronics groups) show 12–18 month execution risk before stable margin pickup; an unintended consequence is increased regulatory/compliance cost that could flip near‑term accretion into dilution.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.32